There are two that I am familiar with for early stage for Neuvax.
This one is in conjuction with Herceptin:
http://www.clinicaltrials.gov/ct2/sh...vaccine&rank=1
The other that was after Herceptin might be in Phase III trials eventually. I'm fairly certain this was the one Dr. Elizabeth Mittendorf and the military were working on. We will be watching Galena Biopharma for upcoming news.
I believe it is too early for AE37 and GP2 for the higher expressors for Phase III. The lower expressors of Her2 are ahead of us in the trials, but you never know. I am expecting great news from the vaccines and am looking forward to more progress in this area.